Search results for "new-drug development"

Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production

Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production

GC Green Cross has secured priority access to critical manufacturing consumables to stabilize the production of Alyglo, its flagship blood product,...
Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68

Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68

Celltrion announced on July 15 that it has received approval from South Korea’s Ministry of Food and Drug Safety for an investigational new drug...
Fast-Tracking Biosimilars: South Korea to Waive Phase 3 Clinical Trials Under New Guidelines

Fast-Tracking Biosimilars: South Korea to Waive Phase 3 Clinical Trials Under New Guidelines

South Korean regulators have revised requirements to significantly reduce the time and financial burden of biosimilar...
Landmark Biotech Deal: Celltrion Acquires Autoimmune Disease Antibody Tech from Catholic University of Korea

Landmark Biotech Deal: Celltrion Acquires Autoimmune Disease Antibody Tech from Catholic University of Korea

A research team led by Kim Wan-wook at the Catholic University of Korea College of Medicine has successfully...
Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch

Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch

Daewoong Pharmaceutical announced on the 13th that its flagship botulinum toxin product, Nabota, surpassed 1 trillion...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio

Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio

Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology...
Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer

Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer

Qurient announced on June 29 that it presented key clinical data highlighting the mechanistic advantages of its...
For Cancer Caregivers, the Dread of Future Costs Harms Health 8 Times More Than Actual Bills

For Cancer Caregivers, the Dread of Future Costs Harms Health 8 Times More Than Actual Bills

For many families navigating a parent or loved one’s cancer diagnosis, sleepless nights become the new normal.
Air Pollution Threatens Skin Health: Fine Dust Increases Psoriasis Risk by Up to 27%

Air Pollution Threatens Skin Health: Fine Dust Increases Psoriasis Risk by Up to 27%

A large-scale study has found that fine dust can severely damage skin health, expanding the known dangers of air...